Key result
Targeting memory T cells may prevent hypertension and renal end-organ damage.
Answers are grounded in this paper and cite their sources.
In recent years, it has become clear that the immune system contributes to the genesis of hypertension. Hypertensive stimuli, such as angiotensin II, DOCA-salt, and norepinephrine, cause T cells and monocytes/macrophages to accumulate in the kidney and vasculature. These cells release inflammatory cytokines, such as IL-6, interferon-γ, and IL-17, that promote renal and vascular dysfunction. These cytokines also promote angiotensinogen production in the proximal tubule and Na(+) retention in the distal nephron and contribute to renal fibrosis and glomerular damage. For several years, we have observed accumulation of memory T cells in the kidney and vasculature. Given the propensity for memory cells to produce cytokines such as interferon-γ and IL-17, interventions to prevent the formation or renal accumulation of specific memory T cell subsets could prevent end-organ damage and blood pressure elevation in response to hypertensive stimuli.
No takes yet. Share an insight, caveat, or question.
Itani et al. (2015) conducted a review in Hypertension. Memory T cells was evaluated. Interventions preventing the formation or renal accumulation of memory T cell subsets could potentially prevent end-organ damage and blood pressure elevation in response to hypertensive stimuli.
Synapse has enriched 10 related papers. Consider them for comparative context: